Q1 FY25 delivered 16% year-over-year sales growth and 23% PAT growth, driven by strong volumes and margin expansion. New HALS products were commercialized, CapEx projects advanced, and capacity utilization is set to rise, supporting future profitability.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.